Pharming Group N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
17 aug 2010 - 18:36
Statutaire naam
Pharming Group N.V.
Titel
PHARMING PROVIDES UPDATE ON OUTSTANDING SHARES
Bericht
Leiden, The Netherlands, August 17, 2010. Biotech company Pharming Group NV (“Pharming”) (NYSE Euronext: PHARM) today announced that its current number of outstanding shares has increased from 332,865,044 at August 5, 2010 to 341,243,169 as per today.
The increase of 8,378,125 shares stems from:? 4,166,667 shares issued under the Standby Equity Distribution Agreement (“SEDA”) with YA Global Master SPV LTD (“YA Global”) for a cash consideration of €750,000. As per today, approximately €22.7 million remains available under the total €30.0 million SEDA facility with YA Global as entered into in 2009;
? an aggregate number of 4,211,458 shares for the conversion of €0.5 million bonds at an exercise price of €0,12. This conversion relates to the €7.5 million January 2010 private bonds. As a result, the original nominal value of the bonds has decreased to €0.4 million today.
? 4,166,667 shares issued under the Standby Equity Distribution Agreement (“SEDA”) with YA Global Master SPV LTD (“YA Global”) for a cash consideration of €750,000. As per today, approximately €22.7 million remains available under the total €30.0 million SEDA facility with YA Global as entered into in 2009;
Gerelateerde downloads
Datum laatste update: 06 februari 2025